Necrostatin-1 Attenuates Inflammatory Response and Improves Cognitive Function in Chronic Ischemic Stroke Mice

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Background:

• Ischemic brain injury involves multiple cell death pathways.
• Necroptosis is a key cell death mechanism in neurons following ischemic injury.
• Necrostatin-1 (Nec-1) is a small molecule inhibitor of necroptosis.

Purpose of the Study:

• To investigate the therapeutic effect of Nec-1 on cognitive function in a mouse model of chronic ischemic stroke.
• To explore the underlying mechanisms of Nec-1's action in mitigating cognitive deficits.

Main Methods:

• Chronic ischemic stroke was induced in 12-week-old C57BL/6 mice using bilateral common carotid artery stenosis (BCAS).
• Mice received intragastric administration of Nec-1 or vehicle for two weeks post-stroke.
• Cognitive function, inflammatory responses, and potential mechanisms were assessed.

Main Results:

• Nec-1 administration significantly prevented cognitive impairment in mice subjected to chronic ischemic stroke.
• Inhibition of necroptosis by Nec-1 reduced the inflammatory response in the ischemic brain.
• These findings indicate a crucial role for necroptosis in stroke-induced cognitive deficits.

Conclusions:

• Inhibition of necroptosis using Nec-1 demonstrates a promising therapeutic strategy for cognitive rehabilitation after chronic ischemic stroke.
• Targeting necroptosis may be a viable approach to improve neurological outcomes in stroke patients.